| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP, Zero Harm | Global VP, Zero Harm | Global VP, She & Process Excel +2 more
1 company
Joseph P Dowd last filed a Form 4 in August 2024, as VP, Zero Harm at KOP.
Our model assigns Joseph P Dowd a strong insider score of 71/100, based on 10 past trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +20.5%.
At the last filing, the largest reported position was 10,300 shares of KOP. The KOP filings lean toward selling, a net 88,117 shares.
Joseph P Dowd has 44 Form 4 filings on record from January 2015 to August 2024, all as VP, Zero Harm at Koppers (KOP), 2015–2024.
The 104 reported transactions were 25 open-market sales, 24 option exercises, 21 tax withholdings and 20 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $19K and 12 sales worth about $3.9M.
The only open-market purchase was 1,000 shares of KOP at an average $18.50 on December 3, 2018, about $19K.
The largest open-market sale was 17,385 shares of KOP at an average $53.53 on March 5, 2024, about $931K. Twelve months later KOP was down 47%.
None of the 8 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
Shares as reported in the last Form 4 for each company; the most recent is from August 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2024 | KOP Koppers Holdings Inc. | VP, Zero Harm | Sell | 5,516 | $37.72 | $208,063.52 | -34.9% | +3.0% | -20.6% | |
| May 17, 2024 | KOP Koppers Holdings Inc. | VP, Zero Harm | Sell | 6,000 | $44.46 | $266,776.00 | -27.5% | -13.3% | -27.9% | |
| Mar 6, 2024 | KOP Koppers Holdings Inc. | VP, Zero Harm | Sell | 1,300 | $52.32 | $68,016.00 | -5.6% | -18.7% | -44.1% | |
| Mar 5, 2024 | KOP Koppers Holdings Inc. | VP, Zero Harm | Sale+OE | 17,385 | $53.53 | $930,571.91 | -43.0% | -17.0% | -46.6% | |
| Mar 1, 2024 | KOP Koppers Holdings Inc. | VP, Zero Harm | Sale+OE | 14,500 | $53.38 | $774,040.29 | -28.2% | -18.4% | -45.0% | |
| Dec 14, 2023 | KOP Koppers Holdings Inc. | VP, Zero Harm | Sell | 2,600 | $45.33 | $117,858.00 | -6.9% | +17.4% | -25.7% | |
| Nov 17, 2023 | KOP Koppers Holdings Inc. | VP, Zero Harm | Sale+OE | 5,250 | $42.46 | $222,915.00 | -12.2% | +20.6% | -15.9% | |
| Jun 6, 2023 | KOP Koppers Holdings Inc. | Global VP, Zero Harm | Sale+OE | 15,265 | $31.42 | $479,626.30 | -28.8% | +21.7% | +41.5% | |
| Feb 28, 2022 | KOP Koppers Holdings Inc. | Global VP, Zero Harm | Sell | 3,000 | $28.51 | $85,530.00 | -8.2% | -5.0% | +26.3% | |
| Feb 28, 2022 | KOP Koppers Holdings Inc. | Global VP, Zero Harm | Sell | 1,749 | $28.75 | $50,283.75 | -5.2% | -5.0% | +26.3% |